154 related articles for article (PubMed ID: 32276090)
1. The solubility, permeability and the dose as key factors in formulation development for oral lipophilic drugs: Maximizing the bioavailability of carbamazepine with a cosolvent-based formulation.
Fine-Shamir N; Beig A; Miller JM; Dahan A
Int J Pharm; 2020 May; 582():119307. PubMed ID: 32276090
[TBL] [Abstract][Full Text] [Related]
2. Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels.
Beig A; Miller JM; Lindley D; Dahan A
Mol Pharm; 2017 Jan; 14(1):319-327. PubMed ID: 27981848
[TBL] [Abstract][Full Text] [Related]
3. Methacrylate-Copolymer Eudragit EPO as a Solubility-Enabling Excipient for Anionic Drugs: Investigation of Drug Solubility, Intestinal Permeability, and Their Interplay.
Fine-Shamir N; Dahan A
Mol Pharm; 2019 Jul; 16(7):2884-2891. PubMed ID: 31120762
[TBL] [Abstract][Full Text] [Related]
4. Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption.
Beig A; Miller JM; Dahan A
Eur J Pharm Biopharm; 2012 Jun; 81(2):386-91. PubMed ID: 22387337
[TBL] [Abstract][Full Text] [Related]
5. Ethanol-based solubility-enabling oral drug formulation development: Accounting for the solubility-permeability interplay.
Fine-Shamir N; Dahan A
Int J Pharm; 2024 Mar; 653():123893. PubMed ID: 38346600
[TBL] [Abstract][Full Text] [Related]
6. Adequate formulation approach for oral chemotherapy: Etoposide solubility, permeability, and overall bioavailability from cosolvent- vs. vitamin E TPGS-based delivery systems.
Fine-Shamir N; Beig A; Dahan A
Int J Pharm; 2021 Mar; 597():120295. PubMed ID: 33497706
[TBL] [Abstract][Full Text] [Related]
7. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.
Van den Bergh A; Van Hemelryck S; Bevernage J; Van Peer A; Brewster M; Mackie C; Mannaert E
Mol Pharm; 2018 Jul; 15(7):2633-2645. PubMed ID: 29799758
[TBL] [Abstract][Full Text] [Related]
9. Improved in vitro and in vivo performance of carbamazepine enabled by using a succinic acid cocrystal in a stable suspension formulation.
Ullah M; Shah MR; Bin Asad MHH; Hasan SMF; Hussain I
Pak J Pharm Sci; 2017 Nov; 30(6):2139-2145. PubMed ID: 29175782
[TBL] [Abstract][Full Text] [Related]
10. Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility-Permeability Interplay.
Beig A; Miller JM; Lindley D; Carr RA; Zocharski P; Agbaria R; Dahan A
J Pharm Sci; 2015 Sep; 104(9):2941-7. PubMed ID: 25989509
[TBL] [Abstract][Full Text] [Related]
11. Solubility-enabling formulations for oral delivery of lipophilic drugs: considering the solubility-permeability interplay for accelerated formulation development.
Fine-Shamir N; Dahan A
Expert Opin Drug Deliv; 2024; 21(1):13-29. PubMed ID: 38124383
[TBL] [Abstract][Full Text] [Related]
12. Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability Interplay.
Beig A; Lindley D; Miller JM; Agbaria R; Dahan A
Front Pharmacol; 2016; 7():379. PubMed ID: 27826241
[TBL] [Abstract][Full Text] [Related]
13. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Singh G; Pai RS
Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
[TBL] [Abstract][Full Text] [Related]
14. The Solubility-Permeability Interplay for Solubility-Enabling Oral Formulations.
Nainwal N; Singh R; Jawla S; Saharan VA
Curr Drug Targets; 2019; 20(14):1434-1446. PubMed ID: 31333138
[TBL] [Abstract][Full Text] [Related]
15. Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension.
Bravo González RC; Huwyler J; Walter I; Mountfield R; Bittner B
Int J Pharm; 2002 Oct; 245(1-2):143-51. PubMed ID: 12270251
[TBL] [Abstract][Full Text] [Related]
16. Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.
Solymosi T; Ötvös Z; Angi R; Ordasi B; Jordán T; Semsey S; Molnár L; Ránky S; Filipcsei G; Heltovics G; Glavinas H
Int J Pharm; 2017 Oct; 532(1):427-434. PubMed ID: 28919099
[TBL] [Abstract][Full Text] [Related]
17. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
Miller JM; Beig A; Carr RA; Spence JK; Dahan A
Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
[TBL] [Abstract][Full Text] [Related]
18. The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.
Miller JM; Beig A; Carr RA; Webster GK; Dahan A
Mol Pharm; 2012 Mar; 9(3):581-90. PubMed ID: 22280478
[TBL] [Abstract][Full Text] [Related]
19. A novel composition of ticagrelor by solid dispersion technique for increasing solubility and intestinal permeability.
Kim SJ; Lee HK; Na YG; Bang KH; Lee HJ; Wang M; Huh HW; Cho CW
Int J Pharm; 2019 Jan; 555():11-18. PubMed ID: 30448313
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
